Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
PYCR1
Introduction
Pyrroline-5-carboxylate reductase 1, mitochondrial is an enzyme that in humans is encoded by the PYCR1 gene.[1][2]
This gene encodes an enzyme that catalyzes the NAD(P)H-dependent conversion of pyrroline-5-carboxylate to proline. This enzyme may also play a physiologic role in the generation of NADP(+) in some cell types. The protein forms a homopolymer and localizes to the mitochondrion. Alternate splicing results in two transcript variants encoding different isoforms.[2]
References
References
Further reading
Further reading
- Herzfeld A, Legg MA, Greengard O (1978). “Human colon tumors: enzymic and histological characteristics”. Cancer. 42 (3): 1280–3. doi:10.1002/1097-0142(197809)42:3<1280::AID-CNCR2820420337>3.0.CO;2-P. PMID 212173.
- Merrill MJ, Yeh GC, Phang JM (1989). “Purified human erythrocyte pyrroline-5-carboxylate reductase. Preferential oxidation of NADPH”. J. Biol. Chem. 264 (16): 9352–8. PMID 2722838.
- Yeh GC, Roth EF, Phang JM, et al. (1984). “The effect of pyrroline-5-carboxylic acid on nucleotide metabolism in erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient subjects”. J. Biol. Chem. 259 (9): 5454–8. PMID 6201483.
- Herzfeld A, Greengard O (1981). “Enzyme activities in human fetal and neoplastic tissues”. Cancer. 46 (9): 2047–54. doi:10.1002/1097-0142(19801101)46:9<2047::AID-CNCR2820460924>3.0.CO;2-Q. PMID 6253048.
- Yeh GC, Harris SC, Phang JM (1981). “Pyrroline-5-carboxylate reductase in human erythrocytes”. J. Clin. Invest. 67 (4): 1042–6. doi:10.1172/JCI110115. PMC 370662. PMID 6894153.
- Maruyama K, Sugano S (1994). “Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Basch JJ, Wickham ED, Farrell HM (1997). “Pyrroline-5-carboxylate reductase in lactating bovine mammary glands”. J. Dairy Sci. 79 (8): 1361–8. doi:10.3168/jds.S0022-0302(96)76493-7. PMID 8880459.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). “Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library”. Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). “Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). “The Status, Quality, and Expansion of the NIH Full-Length cDNA Project: The Mammalian Gene Collection (MGC)”. Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Meng Z, Lou Z, Liu Z, et al. (2006). “Crystal structure of human pyrroline-5-carboxylate reductase”. J. Mol. Biol. 359 (5): 1364–77. doi:10.1016/j.jmb.2006.04.053. PMID 16730026.